Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
OTHER OTC:NKGN
Total Valuation
NKGen Biotech has a market cap or net worth of $9.14M. The enterprise value is $64.31M.
Market Cap$9.14M
Enterprise Value$64.31M
Share Statistics
NKGen Biotech has 130,602,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding130,602,230
Owned by Insiders34.39%
Owned by Institutions2.22%
Financial Efficiency
NKGen Biotech’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -112358.33%.
Return on Equity (ROE)0.00
Return on Assets (ROA)-1.85K
Return on Invested Capital (ROIC)-112358.33%
Return on Capital Employed (ROCE)-1.12K
Revenue Per Employee0.00
Profits Per Employee-702.95K
Employee Count63
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NKGen Biotech is ―. NKGen Biotech’s PEG ratio is 0.00598.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF-0.90
Price to Operating Cash Flow-0.42
PEG Ratio0.00598
Income Statement
In the last 12 months, NKGen Biotech had revenue of 0.00 and earned -44.29M in profits. Earnings per share was -1.54.
Revenue0.00
Gross Profit0.00
Operating Income-26.97M
Pretax Income-44.23M
Net Income-44.29M
EBITDA-26.97M
Earnings Per Share (EPS)-1.54
Cash Flow
In the last 12 months, operating cash flow was -19.65M and capital expenditures -52.00K, giving a free cash flow of -19.70M billion.
Operating Cash Flow-19.65M
Free Cash Flow-19.70M
Free Cash Flow per Share-0.15
Dividends & Yields
NKGen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.86
52-Week Price Change-89.47%
50-Day Moving Average0.06
200-Day Moving Average0.14
Relative Strength Index (RSI)48.36
Average Volume (3m)5.29K
Important Dates
NKGen Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
NKGen Biotech as a current ratio of 0.00, with Debt / Equity ratio of -75.88%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio-9.90
Taxes
In the past 12 months, NKGen Biotech has paid 53.00K in taxes.
Income Tax53.00K
Effective Tax Rate>-0.01
Enterprise Valuation
NKGen Biotech EV to EBITDA ratio is -0.70, with an EV/FCF ratio of -0.90.
EV to Sales0.00
EV to EBITDA-0.70
EV to Free Cash Flow-0.90
EV to Operating Cash Flow-0.90
Balance Sheet
NKGen Biotech has $6.00K in cash and marketable securities with $38.19M in debt, giving a net cash position of -$38.19M billion.
Cash & Marketable Securities$6.00K
Total Debt$38.19M
Net Cash-$38.19M
Net Cash Per Share-$0.29
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 50.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin50.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NKGen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―